HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EWG’s Sunscreen Recommendations Up From 2010, But Health Concerns Remain

This article was originally published in The Rose Sheet

Executive Summary

With FDA’s final sunscreen monograph reportedly around the corner, a greater percentage of sunscreens garnered the Environmental Working Group’s approval this year than in past market surveys, but the group still has concerns about sunscreen regulation and ingredient safety.

You may also be interested in...



EWG Supports Nano-Engineered Mineral Sunscreens In 2013 Report

The Environmental Working Group steers consumers toward mineral-based sunscreens featuring nano-sized zinc oxide and/or titanium dioxide in its 2013 Sunscreen Guide. When used in “appropriate forms,” those sunscreen actives are safer than chemical UV filters, according to EWG.

Children’s Sunscreens Boost EWG Recommendation Rate In 2012

The Environmental Working Group says many children’s sunscreens have “safer, more effective ingredients than those in other products.” But the Personal Care Products Council questions EWG’s research, saying the group’s report “could confuse consumers and discourage them from using sunscreen.”

Children’s Sunscreens Boost EWG Recommendation Rate In 2012

Environmental Working Group says the safest and most effective sunscreens are marketed for babies and kids. In its 2012 U.S. sunscreen report, EWG recommends 25% of 800 beach and sport sunscreens reviewed. Poor marks go to products containing oxybenzone or retinyl palmitate, and FDA remains in group’s Hall of Shame.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017588

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel